Funding Announcements

"Drug discovery is so exciting right now, as there are just so many incredible companies working on remarkable new therapeutics. Equally, we are at a time where there is a stupendous amount of untapped evidence, like cause-and-effect, sat dark and subsequently unused by these same companies. Our mission at Biorelate is to capture this untapped data and help them make sense of it. With this improved understanding we are empowering these companies to make better decisions and speed up the drug discovery process."

"We are delighted to be backing another South West company, and one that promotes diversity and inclusion. RoleMapper offers a unique range of services, some of which would previously have been carried out by large consulting firms at substantial cost. It has rapidly gained traction and attracted an impressive blue-chip client list. The investment will help it to establish itself as a ‘must have’ tool to help organisations navigate the future of work."

"The next generation of software won’t run on code, it will run on models fueled by training data. We let our clients easily turn human knowledge into AI models, improving the safety and accuracy of AI. This is incredibly powerful, and in the right hands, can literally save lives. If we want to build software that tackles unsolved frontiers in human health, or our climate, this is the only way"

"MSD GHI looks forward to enabling acceleration of Turbine’s growth and expansion,"

"Citi Markets uses its deep software expertise to move faster and be more competitive. We find value in Diffblue’s auto-generation of test cases, which helps drive test consistency and coverage of our software. This frees up developers to focus on delivering higher quality software, faster – and improves our developers’ experience,"